These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 21038547

  • 1. Immunohistochemical prognostic criteria in xeroderma pigmentosum.
    Karakok M, Turkmen A, Bekerecioglu M, Koçer NE.
    Int J Dermatol; 2010 Nov; 49(11):1266-71. PubMed ID: 21038547
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, Sangueza OP.
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An evaluation of Ki-67 and PCNA expression in conjunctival and eyelid tumours.
    Reszeć J, Kańczuga-Koda L, Sulkowska M, Koda M, Cylwik J, Barwijuk-Machała M, Sulkowski S.
    Folia Morphol (Warsz); 2004 Feb; 63(1):95-8. PubMed ID: 15039910
    [Abstract] [Full Text] [Related]

  • 8. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J, Rass K.
    Adv Exp Med Biol; 2014 Feb; 810():208-33. PubMed ID: 25207368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer.
    Liang SB, Ohtsuki Y, Furihata M, Takeuchi T, Iwata J, Chen BK, Sonobe H.
    Virchows Arch; 1999 Mar; 434(3):193-9. PubMed ID: 10190297
    [Abstract] [Full Text] [Related]

  • 11. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
    Chang CH, Tsai RK, Chen GS, Yu HS, Chai CY.
    J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
    [Abstract] [Full Text] [Related]

  • 12. Atypical fibroxanthoma and squamous cell carcinoma of the conjunctiva in xeroderma pigmentosum.
    Shao L, Newell B, Quintanilla N.
    Pediatr Dev Pathol; 2007 Oct; 10(2):149-52. PubMed ID: 17378688
    [Abstract] [Full Text] [Related]

  • 13. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 14. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
    Ventéjou S, Bagny K, Waldmeyer J, Cartault F, Machet L, Osdoit S.
    Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China.
    Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, Li JL.
    World J Gastroenterol; 2003 Jan; 9(1):16-21. PubMed ID: 12508343
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P, Parajuli S, Benfodda M, Lebre AS, Paudel U, Grange A, Grybek V, Grange T, Soufir N, Grange F.
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [Abstract] [Full Text] [Related]

  • 19. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.
    Lumachi F, Ermani M, Marino F, Iacobone M, Baldessin M, Cappuzzo G, Zanella S, Favia G.
    Anticancer Res; 2006 May; 26(2A):1305-8. PubMed ID: 16619538
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.